World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
82
Citations
20620
World Ranking
1527
National Ranking
764

Medicine

D-Index
82
Citations
20621
World Ranking
16299
National Ranking
8195

Genoveffa Franchini publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Genoveffa Franchini sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 291 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Genoveffa Franchini D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Genoveffa Franchini sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Genoveffa Franchini is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on immunology and microbiology, with a significant number of publications contributing to the fields of medicine and infectious diseases.

The scientist's work covers several specialized subfields including immunology, virology, agronomy and crop science, infectious diseases, and epidemiology. Their research addresses a range of topics such as HIV research and treatment, immune cell function and interaction, T-cell and retrovirus studies, animal disease management and epidemiology, vector-borne animal diseases, immune responses and vaccinations, as well as immunotherapy and immune responses.

Franchini has published extensively in various scientific journals, with frequent contributions to the following publication venues:

  • Nature Communications
  • PLoS Pathogens
  • Retrovirology
  • Journal of Virology
  • Nature Microbiology

Among their recent papers are:

  • "Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates," published in 2021 in iScience
  • "The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination," published in 2021 in Nature Immunology
  • "The V2 loop of HIV gp120 delivers costimulatory signals to CD4+T cells through Integrin α4β7and promotes cellular activation and infection," published in 2020 in Proceedings of the National Academy of Sciences
  • "NK cells and monocytes modulate primary HTLV-1 infection," published in 2022 in PLoS Pathogens
  • "Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition," published in 2020 in PLoS Pathogens

Genoveffa Franchini collaborates frequently with several researchers, including:

  • Massimiliano Bissa
  • Mohammad Arif Rahman
  • Isabela Silva de Castro
  • Melvin N. Doster
  • Luca Schifanella

Best Publications

  • Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.

    Thi-Sau Migone;Jian-Xin Lin;Anna Cereseto;James C. Mulloy

  • Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus

    Yvette Edghill-Smith;Hana Golding;Jody Manischewitz;Lisa R King

  • Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29).

    R Dalla-Favera;E P Gelmann;S Martinotti;G Franchini

  • Molecular Biology of Human T-Lymphotropic Retroviruses

    Flossie Wong-Staal;Lee Ratner;George Shaw;Beatrice Hahn

  • HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.

    Jakob Nilsson;Adriano Boasso;Paula Andrea Velilla;Rui Zhang

  • Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

    Richard F. Little;Stefania Pittaluga;Nicole Grant;Seth M. Steinberg

  • Superior T memory stem cell persistence supports long-lived T cell memory

    Enrico Lugli;Maria H. Dominguez;Luca Gattinoni;Pratip K. Chattopadhyay

  • Identification of the fusion peptide of primate immunodeficiency viruses.

    Marnix L. Bosch;Patricia L. Earl;Kathleen Fargnoli;Silvia Picciafuoco

  • Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins.

    Shigeki Takemoto;James C. Mulloy;Anna Cereseto;Thi-Sao Migone

  • ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency

    R. Pal;D. Venzon;N. L. Letvin;S. Santra

  • Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

    Igor M. Belyakov;Patricia Earl;Amiran Dzutsev;Vladimir A. Kuznetsov

  • T Cell Receptor Recognition Motifs Govern Immune Escape Patterns in Acute SIV Infection

    David A. Price;Sadie M. West;Michael R. Betts;Laura E. Ruff

  • IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates.

    Terry J. Fry;Marcin Moniuszko;Stephen Creekmore;Susan J. Donohue

  • Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques.

    Igor M. Belyakov;Zdenek Hel;Brian Kelsall;Vladimir A. Kuznetsov

  • Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I.

    I J Koralnik;A Gessain;M E Klotman;A Lo Monico

  • Genomic Evolution, Patterns of Global Dissemination, and Interspecies Transmission of Human and Simian T-cell Leukemia/Lymphotropic Viruses

    Jill Pecon Slattery;Genoveffa Franchini;Antoine Gessain

  • Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from melanesia: genetic and phylogenetic relationship to HTLV-I strains from other geographical regions.

    A Gessain;E Boeri;R Yanagihara;R Gallo

  • The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages.

    Naohiko Hattori;Frank Michaels;Kathleen Fargnoli;Luisa Marcon

  • HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication.

    Christophe Nicot;Christophe Nicot;Miroslav Dundr;Julie M Johnson;Jake R Fullen

  • Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.

    Zdenek Hel;Janos Nacsa;Elzbieta Tryniszewska;Wen-Po Tsai

  • Human T-Cell Lymphotropic/Leukemia Virus Type 1 Tax Abrogates p53-Induced Cell Cycle Arrest and Apoptosis through Its CREB/ATF Functional Domain

    J. C. Mulloy;T. Kislyakova;A. Cereseto;L. Casareto

  • Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques.

    Zdenek Hel;David Venzon;Monita Poudyal;Wen Po Tsai

  • SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection

    Constantinos Petrovas;David A. Price;David A. Price;Joseph Mattapallil;David R. Ambrozak

Frequent Co-Authors

David Venzon
David Venzon National Institutes of Health
Robert C. Gallo
Robert C. Gallo University of South Florida
Marjorie Robert-Guroff
Marjorie Robert-Guroff National Institutes of Health
Phillip D. Markham
Phillip D. Markham Northrop Grumman (United States)
David C. Montefiori
David C. Montefiori Duke University
Christophe Nicot
Christophe Nicot University of Kansas
George N. Pavlakis
George N. Pavlakis Emory University
Ranajit Pal
Ranajit Pal Advanced Bioscience Laboratories (United States)
Gene M. Shearer
Gene M. Shearer National Institutes of Health
Barbara K. Felber
Barbara K. Felber National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related healthcare fields can open diverse career opportunities. Many students consider accelerated routes into nursing, which can complement an immunology background. Searching for accelerated nursing programs near me can be a practical first step for entering clinical roles faster.

Practical nursing programs also offer an accessible path into patient care. Prospective students often seek lpn programs with easiest admission requirements, providing smoother entry into the workforce while gaining valuable hands-on experience.

For advanced practice, nurse practitioner degrees present further specialization opportunities within immunology-related care. Many look for easy nurse practitioner programs to get into to balance rigorous education with achievable admission standards.

Mental health is another vital area connected to immunology, where programs like online pmhnp programs with clinical placement offer convenient training combined with real-world experience.

Exploring these online degrees and career pathways can enhance your expertise and expand your professional options in the evolving healthcare landscape.

Best Scientists Citing Genoveffa Franchini

Trending Scientists

Recently Published Articles